Article Details

AstraZeneca's Evusheld Approved In Japan For Prevention And Treatment Of SARS-CoV-2 Infection

Retrieved on: 2022-08-30 13:17:59

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca's Evusheld Approved In Japan For Prevention And Treatment Of SARS-CoV-2 Infection. View article details on HISWAI: https://www.rttnews.com/3308143/astrazeneca-s-evusheld-approved-in-japan-for-prevention-and-treatment-of-sars-cov-2-infection.aspx

Excerpt

British drug major AstraZeneca Plc. (AZN.L, AZN) announced Tuesday that its Evusheld (tixagevimab and cilgavimab, formerly AZD7442), a long-acting ...

Article found on: www.rttnews.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up